Tolaj infection: About half the world's population is partly immune to coronary

Infectologist Ilir Tolaj has said that about half the world's population, where more and less, appears to be immune to SARS-CoV-2 infection, causing COVID-19, even without prefecting this virus. In a conversation for Klan Kosova, he has stressed that these are the initial findings of a [...]
In a conversation for Klan Kosova, he has stressed that these are the initial findings of a number of research studying COVID-19 in different countries of the world and the role of the immune system in the performance of this disease.
“Studies carried out in several parts of the world, of which the most important are those performed by researchers at Berlin University Hospital Charité published in Science and Research magazine - Singapore's NUS Medical School, published in the science magazine Nature late last month, have shown that non-infected persons' blood samples with the trigger coronavirus of Covid 19 contain SARS T-cellis CoV 2 specifics, in more than 50% of cases analyzed”.
The “T cells, which are also called cytoxic cells, along with the antibodies produced by B cells, are part of the immune human response to viral infections, because of their ability to target and directly kill infected cells”.
Subtitle The SARS-CoV-2, even without ever being the individual in contact with this virus, could be the result of the cross-crossed immunity earned by the exposure to other coronarys, such as those causing ordinary colds in people during the cold months, or the exposure to other animal coronarys still undetectable”.
This data can also explain why some individuals are able to control the infection better than others. People with this particular degree of immunity to SARS-CoV-2, even if they are not completely immune to this infection, when infected with this virus they will be able more effectively to control it and finally to destroy it completely, not allowing infection to develop to such an extent that many organ injuries are lethal to”.
These studies have tremendous epidemiological and clinical significance. Now, reaching collective immunity against The SARS-CoV-2 seems to be much easier and faster; whereas the SARS-CoV-2 specific cells will also be researched for their therapeutic role, in cases where at the beginning of the disease it is found that these are missing, as well as for the discovery of vaccines that would provoke the development of this cell component of the immune system, not just that of the humor that has to do with the <x1).












